In March 2025, the company introduced new plans for any direct-to-client giving of its Wegovy weight loss drug. The company founded a whole new pharmacy, named NovoCare, which would charge consumers $499 a month for entry to the drug, fewer than 50 % the cost of the drug via other pharmaceutical distribution networks.[fifty three]Aspects: Both of t